Sep 152020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA –  Kronos Bio, Inc., a private clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription, today announced the appointment of Elena Ridloff to its Board of Directors as Chair of the Audit Committee. Ms. ...

Kronos Bio appoints Elena Ridloff to its Board of Directors as Chair of the Audit Committee

Kronos Bio appoints Elena Ridloff to its Board of Directors as Chair of the Audit Committee

From:: Kronos Bio appoints Elena Ridloff to its Board of Directors as Chair of the Audit Committee

Sorry, the comment form is closed at this time.